FDA Warning Letter — McGuff Pharmaceuticals, Inc.

Case 481444 — FEI 2022073

The FDA took a Warning Letter action against McGuff Pharmaceuticals, Inc. on Nov 13, 2015 (Santa Ana, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
McGuff Pharmaceuticals, Inc.
Date
Nov 13, 2015
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Santa Ana, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.